Andy Möckel

Andy Möckel has a robust work experience history, starting as a Project Manager at CJD in 2003. Andy then worked their way up to become the General Manager at CJD before moving to Novartis in 2011 as the Brand Director for Allergy/Dermatology. Andy then transitioned to LETIPharma in 2015, where they held roles such as Business Head and eventually became the Managing Director for Central & Northern Europe. In 2020, Andy joined Stallergenes Greer as the Managing Director and then Vice President of Commercial Operations for the D-A-CH Region.

Andy Möckel completed their Master of Business Administration (MBA) in International Executive General Management from Paris Lodron Universität Salzburg in 2011. In 2010, they also pursued Executive General Management, MBA programs at Fudan University and University of Toronto - Rotman School of Management, focusing on Chinese Business Culture, Society, Economy, Financial Market, and Strategic Management. Earlier, in 2009, they attended University of Westminster, London for an Executive General Management, MBA program with a focus on Strategic Management, Supply Chain Management, and Accounting. In 2006, they earned a Master's degree (MAS) in Public Health from Universität Salzburg.